Global Carbocisteine Market Research Report 2019
Table of Contents
Executive Summary
1 Carbocisteine Market Overview
- 1.1 Product Overview and Scope of Carbocisteine
- 1.2 Carbocisteine Segment by Type
- 1.2.1 Global Carbocisteine Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 0.985
- 1.2.3 >98.5%
- 1.3 Carbocisteine Segment by Application
- 1.3.1 Carbocisteine Consumption Comparison by Application (2014-2025)
- 1.3.2 Oral Solution
- 1.3.3 Tablet & Capsule
- 1.3.4 Others
- 1.3 Global Carbocisteine Market by Region
- 1.3.1 Global Carbocisteine Market Size Region
- 1.3.2 North America Status and Prospect (2014-2025)
- 1.3.3 Europe Status and Prospect (2014-2025)
- 1.3.4 China Status and Prospect (2014-2025)
- 1.3.5 Japan Status and Prospect (2014-2025)
- 1.3.6 Southeast Asia Status and Prospect (2014-2025)
- 1.3.7 India Status and Prospect (2014-2025)
- 1.4 Global Carbocisteine Market Size
- 1.4.1 Global Carbocisteine Revenue (2014-2025)
- 1.4.2 Global Carbocisteine Production (2014-2025)
2 Global Carbocisteine Market Competition by Manufacturers
- 2.1 Global Carbocisteine Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Carbocisteine Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Carbocisteine Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Carbocisteine Production Sites, Area Served, Product Types
- 2.5 Carbocisteine Market Competitive Situation and Trends
- 2.5.1 Carbocisteine Market Concentration Rate
- 2.5.2 Carbocisteine Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Carbocisteine Production Market Share by Regions
- 3.1 Global Carbocisteine Production Market Share by Regions
- 3.2 Global Carbocisteine Revenue Market Share by Regions (2014-2019)
- 3.3 Global Carbocisteine Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Carbocisteine Production
- 3.4.1 North America Carbocisteine Production Growth Rate (2014-2019)
- 3.4.2 North America Carbocisteine Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Carbocisteine Production
- 3.5.1 Europe Carbocisteine Production Growth Rate (2014-2019)
- 3.5.2 Europe Carbocisteine Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Carbocisteine Production (2014-2019)
- 3.6.1 China Carbocisteine Production Growth Rate (2014-2019)
- 3.6.2 China Carbocisteine Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Carbocisteine Production (2014-2019)
- 3.7.1 Japan Carbocisteine Production Growth Rate (2014-2019)
- 3.7.2 Japan Carbocisteine Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Carbocisteine Consumption by Regions
- 4.1 Global Carbocisteine Consumption by Regions
- 4.2 North America Carbocisteine Consumption (2014-2019)
- 4.3 Europe Carbocisteine Consumption (2014-2019)
- 4.4 China Carbocisteine Consumption (2014-2019)
- 4.5 Japan Carbocisteine Consumption (2014-2019)
5 Global Carbocisteine Production, Revenue, Price Trend by Type
- 5.1 Global Carbocisteine Production Market Share by Type (2014-2019)
- 5.2 Global Carbocisteine Revenue Market Share by Type (2014-2019)
- 5.3 Global Carbocisteine Price by Type (2014-2019)
- 5.4 Global Carbocisteine Production Growth by Type (2014-2019)
6 Global Carbocisteine Market Analysis by Applications
- 6.1 Global Carbocisteine Consumption Market Share by Application (2014-2019)
- 6.2 Global Carbocisteine Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Carbocisteine Business
- 7.1 Wuhan Grand Hoyo
- 7.1.1 Wuhan Grand Hoyo Carbocisteine Production Sites and Area Served
- 7.1.2 Carbocisteine Product Introduction, Application and Specification
- 7.1.3 Wuhan Grand Hoyo Carbocisteine Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Moehs Iberica
- 7.2.1 Moehs Iberica Carbocisteine Production Sites and Area Served
- 7.2.2 Carbocisteine Product Introduction, Application and Specification
- 7.2.3 Moehs Iberica Carbocisteine Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Afton Pharma
- 7.3.1 Afton Pharma Carbocisteine Production Sites and Area Served
- 7.3.2 Carbocisteine Product Introduction, Application and Specification
- 7.3.3 Afton Pharma Carbocisteine Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Jinshi Pharm
- 7.4.1 Jinshi Pharm Carbocisteine Production Sites and Area Served
- 7.4.2 Carbocisteine Product Introduction, Application and Specification
- 7.4.3 Jinshi Pharm Carbocisteine Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Hengkang Pharma
- 7.5.1 Hengkang Pharma Carbocisteine Production Sites and Area Served
- 7.5.2 Carbocisteine Product Introduction, Application and Specification
- 7.5.3 Hengkang Pharma Carbocisteine Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Globe Quimica
- 7.6.1 Globe Quimica Carbocisteine Production Sites and Area Served
- 7.6.2 Carbocisteine Product Introduction, Application and Specification
- 7.6.3 Globe Quimica Carbocisteine Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Xiangyu Pharmaceutical
- 7.7.1 Xiangyu Pharmaceutical Carbocisteine Production Sites and Area Served
- 7.7.2 Carbocisteine Product Introduction, Application and Specification
- 7.7.3 Xiangyu Pharmaceutical Carbocisteine Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
8 Carbocisteine Manufacturing Cost Analysis
- 8.1 Carbocisteine Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Carbocisteine
- 8.4 Carbocisteine Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Carbocisteine Distributors List
- 9.3 Carbocisteine Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Carbocisteine Market Forecast
- 11.1 Global Carbocisteine Production, Revenue Forecast
- 11.1.1 Global Carbocisteine Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Carbocisteine Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Carbocisteine Price and Trend Forecast (2019-2025)
- 11.2 Global Carbocisteine Production Forecast by Regions (2019-2025)
- 11.2.1 North America Carbocisteine Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Carbocisteine Production, Revenue Forecast (2019-2025)
- 11.2.3 China Carbocisteine Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Carbocisteine Production, Revenue Forecast (2019-2025)
- 11.3 Global Carbocisteine Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Carbocisteine Consumption Forecast (2019-2025)
- 11.3.2 Europe Carbocisteine Consumption Forecast (2019-2025)
- 11.3.3 China Carbocisteine Consumption Forecast (2019-2025)
- 11.3.4 Japan Carbocisteine Consumption Forecast (2019-2025)
- 11.4 Global Carbocisteine Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Carbocisteine Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions.
Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions.
In the last several years, Global market of Carbocisteine developed steady, with an average growth rate of 5.2%. In 2016, Global Revenue of Carbocisteine is nearly 35 M USD; the actual production is about 1600 MT.
The classification of Carbocisteine includes 98.5% and >98.5%, and the sales proportion of >98.5% in 2016 is about 76.2%.
Carbocisteine is widely used to make drugs, the formal of drugs include Oral Solution, Tablet & Capsule and Other. The most proportion of Carbocisteine formal is Tablet & Capsule and the proportion in 2016 is about 74%.
China is the largest supplier of Carbocisteine, with a revenue market share nearly 46% in 2016. India is the second largest supplier of Carbocisteine, enjoying revenue market share nearly 25% in 2016.
Europe is the largest consumption place, with a consumption market share nearly 33% in 2016. Following Europe, China is the second largest consumption place with the consumption market share of 26%.
Market competition is not intense. Wuhan Grand Hoyo, Moehs Iberica, Afton Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Carbocisteine market is valued at 44 million US$ in 2018 is expected to reach 61 million US$ by the end of 2025, growing at a CAGR of 4.1% during 2019-2025.
This report focuses on Carbocisteine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Carbocisteine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Wuhan Grand Hoyo
Moehs Iberica
Afton Pharma
Jinshi Pharm
Hengkang Pharma
Globe Quimica
Xiangyu Pharmaceutical
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
0.985
>98.5%
Segment by Application
Oral Solution
Tablet & Capsule
Others